Future Possibilities and Speculations about IPT
by Chris Duffield
Ophthalmology researchers ought to look into IPT. Here are some clues that IPT could enable better and faster treatment of eye
- IPT has been shown, time after time, to improve transport of medications
across the cell membranes and into otherwise impermeable tissues throughout
the body. I suggest that it is very likely that IPT will assist
transport of medications to be delivered, and toxins to be eliminated,
across the blood-aqueous barrier, the blood-vitreous barrier,
and the blood-retinal barrier. This would be an entirely new
strategy for getting drugs into the eyes. Eye specialists may develop
empirical methods that intentionally use these transport
- The US insulin study group of the 1930s
reported improvements in vision after injection of small amounts of slow
insulin into the body. Their theory and observation was that
ectodermal tissue would be most affected by insulin, and the optic nerve, retina, and
lens are of ectodermal origin. Two quotes from the review
paper: "Still another
[doctor], using insulin for a periodontal case, found simultaneous
improvement in the patients long standing double vision."
"Dramatic results have been noted in people with certain eye problems.
Retrobulbar neuritis has responded back to normal with three injections over a period of two weeks.
'Leaky' retinas have stopped leaking after two to three injections, but treatment is usually continued for three weeks. Injections for eye problems
(ectodermally related) are given where a dentist gives an anesthetic for an upper first or second bicuspid.
Injection is shallow." It could be that IPT will be even more
effective, especially when combined with appropriate
- This mention of the stopping of retinal leaking could be very
significant. Age-related macular degeneration (AMD) is the
leading cause of vision loss with aging. "Wet" macular
degeneration, the most serious kind, is responsible for 90 percent of the
severe loss of vision, and with some 200,000 new cases per year in the US
alone. Wet AMD involves neovascularization (new blood vessels) in the
retina, which then begin to leak and cause irreversible damage. Laser
photocoagulation can seal the leaks, but at the cost of damaging more
retinal area. Some other methods are being tried, including
antiangiogenic drugs, sub-macular surgery, and laser photodynamic
therapy. All of these methods are expensive, requiring advanced
technologies out of the reach to most human beings who need help.
Wouldn't it be wonderful if a few injections of slow insulin stopped retinal
leaking as a few doctors claimed in the 1930s? Wouldn't it be
wonderful if a simple, inexpensive IPT treatment could be developed for
- One of Dr. Paquette's patients: "This journalist treated for circulatory troubles who, the day after her
treatment, while trying to read her newspaper, exclaimed aggressively: "How
it is that I cannot read with my glasses?" I told her to remove them.
Surprised, she realized that she could read without her glasses for the first
time in 5 years." Perhaps IPT will be found to be able to rejuvenate
the lens of the eye in people past middle age, so that its range of focus
increases. Can IPT reduce or eliminate the need for reading glasses?
- Another of Dr. Paquette's patients, a young
actress with viral hepatitis. "In a few days, after the ICT treatment, her blood chemistry
becomes normal again, to her great surprise her vision and hearing improve."
- Dr. Paquette wrote that when he noticed yellowish
corneas, he immediately suspected liver toxicity and biliary dyskinesia.
It could be that detoxification of the liver and the body with IPT could reduce or
reverse this symptom.
[IPTQ Webhost Update
7/11/03: A biliary dyskinesia patient has suggested that Dr. Paquette's
ideas about this condition are incorrect or out of date. She provided
these links for more recent information:
It appears that Dr. Paquette was using this term to refer to a wider range of
problems, "Bad elimination of bile", which IPT might be able to address.]
- There is some evidence that diabetes-related loss of vision may
be treatable with IPT. The Drs. Perez Garcia report such
a case in the 1992 patent. "At the end of the first IPT treatment the patient reported
improvement in his eyesight."
- I believe that somewhere in my archives is at least one case study of rapid and successful
IPT treatment of glaucoma by Dr. Perez Garcia y Bellon 2.
- Retinitis pigmentosa is a group of hereditary disorders whose common feature is a gradual deterioration of the light sensitive cells of the
retina. IPT could be an efficient way to deliver drugs and
nutrients across the blood-retinal barrier, which could open the way to
innovative treatments to slow or halt the processes of chronic